Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Postmarketing Safety: US FDA ‘Best Practices’ Include Weekly Adverse Event Screening For New Drugs
Nov 10 2019
•
By
Sue Sutter
US FDA takes a close look at adverse event reports every week for newly approved drugs. • Source: Shutterstock
More from Drug Safety
More from Pink Sheet